BCG vaccines: WHO position paper

La posición de la OMS frente a la vacunación
Tuberculosis
Múltiples regiones
Título(s) original(es)
BCG vaccines: WHO position paper
Autor(es)
WHO
Topics
recommendation
Fuente(s)
OMS/Wer Parte Epidemiológico Semanal
Año de publicación
2018

Descripción

This position paper replaces the 2004 WHO position paper on Bacille Calmette-Guérin (BCG) vaccine1 and the 2007 WHO revised BCG vaccination guidelines for infants at risk for human immunodeficiency virus (HIV) infection. It incorporates recent developments in the field of tuberculosis, provides revised guidance on the immunization of children infected with HIV, and re-emphasizes the importance of the BCG birth dose. This position paper also includes recommendations on the use of BCG for the prevention of leprosy. Recommendations on the use of BCG vaccines were discussed by SAGE in October 2017; evidence presented at the meeting can be accessed at: www.who.int/immunization/sage/meetings/2017/october/presentations_background_docs/en/.

Noticias y eventos relacionados

  • Chile
    Functionamiento

    Chile's NITAG documents the results of the committee's evaluation

    02.07.2019

    In this article, we describe the structure, functioning and work processes of Chile’s NITAG (CAVEI) and assess its functionality, quality of work processes and outputs, and integration of the committee into the Ministry of Health policy process using the Assessment tool for National Immunization Technical Advisory Groups.

    Leer más
  • NITAG training

    Read more on NITAG training in resource-constrained settings

    20.06.2019

    Antoinette Ba-Nguy and Adeel Shaah, ex-SIVAC staff and experienced NITAG trainers,  wrote an article on the NITAG trainings delivered through the Partnership for Influenza Vaccine Introduction (PIVI) program.

    Leer más
  • GEAE (Grupo de Expertos de Asesoramiento Estratégico)

    new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

    13.05.2019

    Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

    Leer más